Ad-O-Lytics Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Ad-O-Lytics General Information
Description
Developer of oncolytic virotherapy systems designed to deliver cancer treatments via the bloodstream. The company's platform enables the systemic administration of tumor-dissolving viruses, targeting both primary tumors and metastases, enabling healthcare providers to offer a potential breakthrough in cancer treatment by providing a less invasive and more effective therapy option.
Contact Information
Website
www.adolytics.comCorporate Office
- Ulm
- Germany
Corporate Office
- Ulm
- Germany
Ad-O-Lytics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | Completed | Out of Business | ||||
| 2. Grant | 08-Nov-2016 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2016 | $2.18K | $2.18K | Completed | Startup |
Ad-O-Lytics FAQs
-
When was Ad-O-Lytics founded?
Ad-O-Lytics was founded in 2016.
-
Where is Ad-O-Lytics headquartered?
Ad-O-Lytics is headquartered in Ulm, Germany.
-
What industry is Ad-O-Lytics in?
Ad-O-Lytics’s primary industry is Drug Discovery.
-
Is Ad-O-Lytics a private or public company?
Ad-O-Lytics is a Private company.
-
What is Ad-O-Lytics’s current revenue?
The current revenue for Ad-O-Lytics is .
-
How much funding has Ad-O-Lytics raised over time?
Ad-O-Lytics has raised $2.18K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process